BCRX
$7.79-2.87%
BioCryst Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.007%Russell 3000 0.004%US Stock Market 0.004%
BioCryst Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
BioCryst Pharmaceuticals Inc. total returns by year (1995–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $7.80 | $7.79 | 0.0% | -0.1% | |
| 2025 | $7.52 | $7.80 | 0.0% | +3.7% | |
| 2024 | $5.99 | $7.52 | 0.0% | +25.5% | |
| 2023 | $11.48 | $5.99 | 0.0% | -47.8% | |
| 2022 | $13.85 | $11.48 | 0.0% | -17.1% | |
| 2021 | $7.45 | $13.85 | 0.0% | +85.9% | |
| 2020 | $3.45 | $7.45 | 0.0% | +115.9% | |
| 2019 | $8.07 | $3.45 | 0.0% | -57.2% | |
| 2018 | $4.91 | $8.07 | 0.0% | +64.4% | |
| 2017 | $6.33 | $4.91 | 0.0% | -22.4% | |
| 2016 | $10.32 | $6.33 | 0.0% | -38.7% | |
| 2015 | $12.16 | $10.32 | 0.0% | -15.1% | |
| 2014 | $7.60 | $12.16 | 0.0% | +60.0% | |
| 2013 | $1.42 | $7.60 | 0.0% | +435.2% | |
| 2012 | $2.47 | $1.42 | 0.0% | -42.5% | |
| 2011 | $5.17 | $2.47 | 0.0% | -52.2% | |
| 2010 | $6.46 | $5.17 | 0.0% | -20.0% | |
| 2009 | $1.37 | $6.46 | 0.0% | +371.5% | |
| 2008 | $6.18 | $1.37 | 0.0% | -77.8% | |
| 2007 | $11.56 | $6.18 | 0.0% | -46.5% | |
| 2006 | $16.75 | $11.56 | 0.0% | -31.0% | |
| 2005 | $5.78 | $16.75 | 0.0% | +189.8% | |
| 2004 | $6.85 | $5.78 | 0.0% | -15.6% | |
| 2003 | $0.96 | $6.85 | 0.0% | +613.5% | |
| 2002 | $3.96 | $0.96 | 0.0% | -75.8% | |
| 2001 | $6.63 | $3.96 | 0.0% | -40.2% | |
| 2000 | $29.50 | $6.63 | 0.0% | -77.5% | |
| 1999 | $7.00 | $29.50 | 0.0% | +321.4% | |
| 1998 | $7.00 | $7.00 | 0.0% | +0.0% | |
| 1997 | $16.38 | $7.00 | 0.0% | -57.3% | |
| 1996 | $9.25 | $16.38 | 0.0% | +77.0% | |
| 1995 | $4.63 | $9.25 | 0.0% | +100.0% |
- Annualized
- +1.1%
- 1995–2026
- Average year
- +55.8%
- 31 full years
- Best year
- +613.5%
- 2003
- Worst year
- -77.8%
- 2008
- Positive years
- 13/31
- 42% up
Annualized (CAGR)
+1.1%
1995–2026
Average year
+55.8%
31 full years
Best year
+613.5%
2003
Worst year
-77.8%
2008
Positive years
13/31
42% up
Total return by period#
Annual
-600%-400%-200%0%200%400%600%
1995+100%'95
1996+77%
1997-57%
19980%'98
1999+321%
2000-78%
2001-40%'01
2002-76%
2003+614%
2004-16%'04
2005+190%
2006-31%
2007-47%'07
2008-78%
2009+372%
2010-20%'10
2011-52%
2012-43%
2013+435%'13
2014+60%
2015-15%
2016-39%'16
2017-22%
2018+64%
2019-57%'19
2020+116%
2021+86%
2022-17%'22
2023-48%
2024+26%
2025+3.7%'25
2026-0.13%
Methodology#
Total returns, dividends reinvested, measured on BCRX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is BioCryst Pharmaceuticals Inc.'s average annual return?
- Since 1995, BioCryst Pharmaceuticals Inc. (BCRX) has returned about 1.1% a year (the compound annual growth rate) and an average calendar-year return of 55.8%.
- What were BioCryst Pharmaceuticals Inc.'s best and worst years?
- Over 1995–2026, the best year was 2003 (+613.5%) and the worst was 2008 (-77.8%).
- How often is BioCryst Pharmaceuticals Inc. up in a year?
- 13 of the 31 full years since 1995 were positive — about 42% of the time.
More on BioCryst Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100